GlobalData provides unique and market-leading data and insights into the hematology market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Hemophilia A and B – Global Drug Forecast and Market Analysis, 2021-2030

  • $10,995
  • December 2021
Hemophilia A and B are rare disorders in coagulation, characterized by the failure of blood to form normal clots after damage to veins and tissue. The patient population is increasing...

Thrombocytopenia – Global Clinical Trials Review, H2, 2021

  • $2,500
  • November 2021
GlobalData's clinical trial report, “Thrombocytopenia - Global Clinical Trials Review, H2, 2021" provides an overview of Thrombocytopenia Clinical trials scenario. This report provides top line data relating to the clinical...

Neutropenia – Global Clinical Trials Review, H2, 2021

  • $2,500
  • November 2021
GlobalData's clinical trial report, “Neutropenia - Global Clinical Trials Review, H2, 2021" provides an overview of Neutropenia Clinical trials scenario. This report provides top line data relating to the clinical...

Sickle Cell Disease – Global Clinical Trials Review, H2, 2021

  • $2,500
  • November 2021
GlobalData's clinical trial report, “Sickle Cell Disease - Global Clinical Trials Review, H2, 2021" provides an overview of Sickle Cell Disease Clinical trials scenario. This report provides top line data...

Hemophilia A and B – Epidemiology Forecast to 2030

  • $3,995
  • October 2021
Hemophilia is an X-linked hereditary bleeding disorder characterized by impaired blood coagulation because of deficiencies in the production or function of coagulation factor VIII in hemophilia A or factor IX...

Sickle Cell Disease – Global Clinical Trials Review, H1, 2021

  • $2,500
  • May 2021
GlobalData's clinical trial report, “Sickle Cell Disease - Global Clinical Trials Review, H1, 2021" provides an overview of Sickle Cell Disease Clinical trials scenario. This report provides top line data...

Neutropenia – Global Clinical Trials Review, H1, 2021

  • $2,500
  • May 2021
GlobalData's clinical trial report, “Neutropenia - Global Clinical Trials Review, H1, 2021" provides an overview of Neutropenia Clinical trials scenario. This report provides top line data relating to the clinical...

Thrombocytopenia – Global Clinical Trials Review, H1, 2021

  • $2,500
  • May 2021
GlobalData's clinical trial report, “Thrombocytopenia - Global Clinical Trials Review, H1, 2021" provides an overview of Thrombocytopenia Clinical trials scenario. This report provides top line data relating to the clinical...

Chronic Kidney Disease Anemia – Global Drug Forecast and Market Analysis to 2029

  • $10,995
  • March 2021
Anemia is a common complication of chronic kidney disease (CKD) that is most frequently attributed to insufficient synthesis of erythropoietin (EPO) due to kidney damage. CKD anemia is highly prevalent...

Chronic Kidney Disease-Anemia – Epidemiology Forecast to 2029

  • $3,995
  • February 2021
The diagnosed prevalent cases of chronic kidney disease-anemia (CKD-anemia) in the eight major markets (*8MM) are projected to increase from four million cases in 2019 to 4.5 million cases in...